Neonatal Screening for Genetic Blood Diseases. Shaikha Al-Arayyed, PhD* A Aziz Hamza, MD** Bema Sultan*** D. K. Shome, MRCPath**** J. P.

Similar documents
Beta Thalassemia Frequency in Bahrain: A Ten Year Study. Shaikha Salim Al-Arrayed, MB,ChB, DHCG, PhD*

Public Awareness of Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency

Public awareness of sickle cell disease in Bahrain

Maternal Mortality in Women with Sickle Cell Disease. Zainab Al-Jufairi, MHPE, FRCOG* Amarjit Sandhu, MD, FRCOG*

Survey for glucose-6- phosphate dehydrogenase enzyme deficiency among premarital attendanceinniava

Proposed low-cost premarital screening program for prevention of sickle cell and thalassemia in Yemen Hafiz Al-Nood 1 Abdulrahman Al-Hadi 2

High Hemoglobin F in a Saudi Child Presenting with Pancytopenia

Prevalence of Sickle Cell Anemia and Thalassemia among Anemic Patients of Al-Noor Specialist Hospital, Makkah, KSA

Abstract. Fatima Al Alawi (1) Watheq A. Hashim (2) Ghaida Abdulla (1) Adel Al Sayyad (3)

Cover Page. The handle holds various files of this Leiden University dissertation.

754 La Revue de Santé de la Méditerranée orientale, Vol. 10, N o 6, Invited paper Iron deficiency anaemia an old enemy K.

Counselling and prenatal diagnosis. Antonis Kattamis, Greece

The Beats of Natural Sciences Issue 3-4 (September-December) Vol. 3 (2016)

Thalassaemia and other haemoglobinopathies

BETA GLOBIN GENE HAPLOTYPES IN BAHRAINI PATIENTS WITH SICKLE CELL ANAEMIA

Thalassaemia and Abnormal Haemoglobins in Pregnancy

Screening for haemoglobinopathies in pregnancy

Utility of hemoglobin electrophoresis to detect hemoglobinopathies in adults not presenting with hematological problems

Community Genetics. Hanan Hamamy Department of Genetic Medicine & Development Geneva University Hospital

Comprehensive Newborn Screening Program: ARAMCO Experience, The National Need and Recommendations

1. Prevalence of genetic disorders of haemoglobins in the hospital population of Bahrain

Evaluation of hemoglobinopathy screening results of a six year period in Turkey

Carrying Beta Thalassaemia A carrier can use this booklet to

Epidemiology, Care and Prevention of Hemoglobinopathies

Original Paper. Inherited Haemoglobin Disorders Among Apparently Healthy Individuals- An Analysis of 105 Cases. Abstract

Bahrain Branch of Cochrane Collaboration: Six Years of Achievement. Amani Al Hajeri MD, CABFM, IBFM, MSc MG*, Zbys Fedorowicz, MSc, DPH BDS**

Dr. Ayman Mohsen Mashi, MBBS Consultant Hematology & Blood Transfusion Department Head, Laboratory & Blood Bank King Fahad Central Hospital, Gazan,

Detection of Hemaglobinopathies in Anemic Children by HPLC method A Hospital Based Study

HPLC profile of sickle cell disease in central India

The study was cross-sectional, conducted during the academic year 2004/05.

Research Article β-thalassemia Mutations among Transfusion-Dependent Thalassemia Major Patients in Northern Iraq

Sickle Cell Anemia A Fictional Reconstruction Answer Key

BRCA Testing in Ovarian cancer Arabic Approach

The pros and cons of the fourth revision of thalassaemia screening programme in Iran

sickle haemoglobin, G6PD deficiency, and a and thalassaemia

International Journal of Health Sciences and Research ISSN:

Thalassemias. Emanuela Veras, M.D. 01/08/2006

Cancer Incidence and Mortality in the Kingdom of Bahrain Statistics and Trends

Human Genetic Diseases. AP Biology

Maternal Health in Arab States

Glucose tolerance test in pregnancy. Maternity Department Patient Information Leaflet

Results of Newborn Blood-Spot screening

Report of Beta Thalassemia in Newar Ethnicity

The Effect of Hydroxyurea Treatment on Fetal Haemoglobin Level and Clinical Status of Sudanese Sickle Cell Anaemia Patients

Original Article. Abstract INTRODUCTION. Hussain A. Al-Suwaid, Magdy A. Darwish, Amr A. Sabra

Proportion (%) of population with haemoglobin below: 1 Jeddah City: SAC by sex F Jeddah City: SAC by sex M

Investigation of sickle cell disease

Human Genetic Diseases (Ch. 15)

Diabetes management: lessons from around the globe MENA. J. Belkhadir (Morocco)

Comparison between PCR based Single Tube Genotyping of Sickle. Cell Disease and Alkaline Haemoglobin Electrophoresis

6.1 Extended family screening

Index. Note: Page numbers of article titles are in boldface type.

HEMOLYTIC ANEMIA DUE TO ABNORMAL HEMOGLOBIN SYNTHESIS

The Pattern for Common Anaemia among Saudi Children

b-globin Gene Cluster Haplotypes in Sickle Cell Patients From Southwest Iran

HAEMATOLOGY CASE STUDIES SICKLE CELL SS

Human Genetic Diseases. AP Biology

Genetics of Thalassemia

Genetic Disorders in the United Arab Emirates: A 2006 Update

Haemoglobin BY: MUHAMMAD RADWAN WISSAM MUHAMMAD

H aemoglobin A2 can be measured by several laboratory

Barriers to Quit Smoking among Adult Smokers

Success of Iran beta thalassemia prevention program:

VALIDATION OF OSMOTIC FRAGILITY TEST AND DICHLOROPHENOL INDOPHENOL PRECIPITATION TEST FOR SCREENING OF THALASSEMIA AND Hb E

Regional meeting on haemoglobinopathies and genetic diseases in the Eastern Mediterranean Region

Glucose-6-Phosphate Dehydrogenase Deficiency Correlation between Genotype and Phenotype

Progress report on the achievement of the health-related Millennium Development Goals and global health goals after 2015

SICKLE CELL DISEASE. Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH. Assistant Professor FACULTY OF MEDICINE -JAZAN

The data were analysed using Fisher s exact test and the chi-squared test.

Quiz. What percentage of the world s population is a carrier of a hemoglobinopathy? Hemoglobinopathies in Pregnancy 1-2% 5-7% 8-12% 10-15%

Information for adult haemoglobinopathy carriers You are a haemoglobin C carrier Your test result shows: Hb AC

Hematological profile among Sudanese patients with sickle cell anemia

JMSCR Vol 06 Issue 01 Page January 2018

A study on the awareness and perception of Bahraini adult sickle cell patients towards the preventive measures of sickle cell crisis

Zeina Al-Assaf. Mustafa Khader. Nayef Karadsheh

Cancer in the Arabian Gulf Kingdom of Bahrain ( ) Fayek A Alhilli, PhD (Path)* Nagalla S Das, MD*

HEMOGLOBIN ELECTROPHORESIS DR ARASH ALGHASI SHAFA HOSPITAL-AHWAZ

Information for adult haemoglobinopathy carriers

Introduction reduction in output alter the amino acid sequence combination

Comprehensive Hemoglobin Analysis HBA1/2 (

Genetic Diversity of 3-thalassemia Mutations in Pakistani Population

Should Universal Carrier Screening be Universal?

Each person has a unique set of characteristics, such as eye colour, height and blood group.

GENETIC SCREENING. Prof Dr Karen Sermon, MD, PhD LEARNING OBJECTIVES DISCLOSURE

Congenital Haemoglobinopathies

Thalassemias:general aspects and molecular pathology

Line Probe Assay for Detection of Alpha Thalassemia: A Pilot Study

Screening for sickle cell disease and thalassaemia. An easy guide to screening tests when you are pregnant

Cover Page. The handle holds various files of this Leiden University dissertation.

Eastern Mediterranean Region Framework for health information systems and core indicators for monitoring health situation and health system

Sickle Cell Disorder Referral Guidelines for Newborn Bloodspot Screening Wales Screening for Sickle Cell Disorder in Wales started on 1 June 2013

Evaluating premarital screening knowledge in Saudi students

got anemia? IT COULD BE THALASSEMIA TRAIT

Hemoglobinopathies Diagnosis and management

Prevalence and pattern of sickle cell disease in premarital couples in Southeastern Nigeria

Joanne Mallon, Nora O Neill, Dr D Hull Antenatal midwife coordinator, Consultant Haematologist

Glucose-6-phosphate dehydrogenase deficiency among newborn in Brunei Darussalam

A Prospective & Multicentric Study of RBC Parameters in Patients of Sickle Cell Disorder

HETEROZYGOUS BETA THALASSEMIA IN PARENTS OF CHILDREN WITH BETA THALASSEMIA MAJOR

Prevalence and Molecular Identification of Mediterranean Glucose-6-Phosphate Dehydrogenase Deficiency in Khuzestan Province, Iran

Transcription:

Bahrain Medical Bulletin, Vol. 29, No. 3, September, 2007 Neonatal Screening for Genetic Blood Diseases Shaikha Al-Arayyed, PhD* A Aziz Hamza, MD** Bema Sultan*** D. K. Shome, MRCPath**** J. P. Bapat,PhD**** Background: Previous neonatal screening in 1986 showed that the incidence of sickle cell disease (SCD) is 2.1% and (SCT) is l1%. Since 1984 the Ministry of Health (MOH) instituted a prevention campaign. The incidence has been falling gradually since then. Objective: To update the national data on the incidence of SCD among the newborns and to compare it with the previously available data. Method: All Bahraini newborns delivered at the (MOH) maternity hospitals for a period of three months from February to April 2002 were targeted. Cord blood samples were analyzed by HPLC. Result: Two thousand newborns constituted the study population five were excluded. Eighteen were found to be affected with SCD with an incidence of 0.9%. SCT was found in 325 (16.3%). G6PD deficiency was found in 18% of males, and 10% of females. Parental age distribution and consanguinity were documented. Conclusion: Bahrain has for the first time recorded less than 1% babies with SCD. Bahrain Med Bull 2007; 29(3): Sickle cell disease and thalassemia are common in many parts of the world especially in tropical Africa, the Middle East, the Mediterranean basin, the Indian subcontinent and South America. Experimental evidence and Epidemiological studies support the argument that the heterozygote state of hemoglobinopathies may provide some protection against Malaria. Many studies indicate that these diseases are common in the Gulf region, in Saudi Arabia, Bahrain, Kuwait, United Arab Emirates, Oman and Qatar. These diseases are also common in the other Arab countries such as Egypt, Iraq, Syria, Jordan, Palestine, and Lebanon etc 1-5. * Genetic Department This study is a collaborative project between the ** Under Secretary Ministry of Health, the World Health *** Nursing Department Organization, and the Bahrain Hereditary **** Pathology Department Anemia Society. The national Hereditary Salmaniya Medical Centre Disease Committee had organized and directed Kingdom of Bahrain the project.

The diseases are chronic and the affected person suffers from anemia and ill health all through his life. Preventive measures remain the best way of reducing the incidence of the diseases 1,2. In Bahrain, a previous neonatal screening done between the years 1984-1986 showed that the incidence of sickle cell disease (SCD) is 2.1%, sickle cell thalassemia (SCT) is 11%, alpha thalassemia trait 20% and Glucose six phosphate deficiency 25% of live births 7,8. In contrast to the premarital study done in 1995, which showed a prevalence of 1.6% 9. The prevalence figure was also lower in the student-screening project conducted in 1999, as the prevalence of SCD homozygous was found to be 1.2% 10. This may indicate a gradual decline in disease frequency, which may be due to the effect of increased awareness among the people of Bahrain, as a result of the educational and awareness campaign which was started some twenty years ago. The aim of this study is to update the national data on the incidence of SCD among the newborns and to compare it with the previously available data. METHOD The study was performed between February 1 and April 30, 2002. The target group included 2000 Bahraini newborn delivered in the Ministry of Health maternity hospitals. Cord blood samples were collected in tubes containing EDTA, and transferred to the Hematology Laboratory at Salmaniya Medical Complex for analysis. High performance liquid chromatography was used to perform electrophoresis on the cord blood samples, with a fluorescent screening technique for G6PD deficiency. A questionnaire was completed for each new born. The form included characteristic data, parental age group, and consanguinity and was coded for computerization. Senior personnel in each field undertook the requisite training of involved doctors, nurses and technicians. A confirmatory test was conducted on all the newborns with abnormal results. RESULT The total number of samples analyzed was 1995; five of the samples were excluded because the blood had clotted. Male to female ratio among the sample group was 1.1/1 with slight excess of males. The paternal age distribution shows that the majority of the fathers were aged between 25 44 years (87%), and 29% were 30-39 age group.

Maternal age distribution shows a lower figure, with most women having children between the ages of 20 39 (82%); the majority of these were between the ages of 25 34 years (57%). Consanguinity rate: marriages between relatives was found to be 20% (242/1197), with first cousin marriages of 12.5% (150/1187) and 7% (92/1187) for marriages between distant relatives. Only 0.9% (18/1995) of Bahraini neonates, born in Ministry of Health facilities had Sickle cell disease SCD, while sickle cell trait was found in 16.3% (325/1995) of the newborns, see table 1. Table 1: Sickle Cell Disease & Sickle Cell Trait Frequency among New Born, Mothers and fathers, 2002 Status Glucose 6 phosphate dehydrogenase deficiency, which represented 28% of the total, was found in 10% of the male newborns, and 18% of the female newborns. DISCUSSION Child Mother Father No % No % No % Normal 1652 82.81% 1024 84.63% 234 90% Carrier 325 16.29% 170 14.05% 21 8.08% Disease 18 0.9% 16 1.32% 5 1.92% Total No 1995 1210 260 The male to female ratio among the samples was 1.1/1 with a slight excess of males.

The paternal age distribution showed that the majority have children at 20 54 years; the maternal age distribution of the mother is lower, majority between 20 29 years. Consanguinity rate: marriages between relatives was found to be 20% (242/1197), with first cousin marriages of 12.5% (150/1187) and 7% (92/1187) for marriages between distant relatives. The previous figure in the year 1995 was 39% consanguinity and 24% first cousin marriage 11. In the year 1998 the figure was 32% consanguinity and 24% for first cousin marriage 12. Accordingly there is a gradual decline in the rate of marriages between relatives. The study showed that only 18 of the 1995 newborn (0.9%) were affected with SCD. The 0.9% SCD birth prevalence in 2002 compared with the previous estimate of 2.1% reported in 1984-85, indicates a decline by almost 60% (p = 0.001). The sickle cell trait prevalence of 16.3% in 2002 compared with previous estimates of 11% in 1986 (p = 0.001) (table 2), 13% in student screening during 1998, and 14% in 2001 demonstrates an increasing trend. As shown from table 1, the incidence of SCD was higher in the parents than their children. The trait rate showed the opposite trend, which has been expected as more carriers (HbA/HbS) marry normal persons with HbA/HbA. There was a significant reduction in the birth prevalence of SCD between 1986 and 2002 (p=0.001). Similarly, there was a significant increase in the frequency of carriers during that time (p = 0.001), see table 2. Table 2: Comparison of the prevalence of SCD and SC carriers frequency in 1986 and 2002 Year No Screened No Affected No Carriers 1986 10,327 217 (2.1%) 1.8 2.4) 1,135 (11%) (interval analysis 1.04 11.6) 2002 2,000 18 (interval analysis 1.326 (interval analysis 0.5 1.42) 14.7 18.0) p 0.001 0.001 A previous molecular study showed that approximately 90% of patients had the mild form of sickle cell disease 17. DNA analysis has proved the presence of the Asian as the common haplotype 13-17. This mutation is associated with high level of HbF, a situation similar to that in the Eastern Province of Saudi Arabia. In contrast to the common gene found in Oman and western province of Saudi Arabia where the severe type of the disease predominate and the common haplotype is the benign haplotype 18,19. G6PD deficiency of 18%, in male and 10% in female newborns, the total is 28%, compared favourably with almost 25% in many previous studies.

The Lyon hypothesis indicates that female heterozygotes have one normal gene for G6PD, and one of the X is active. If the active X has the defective gene, the disease will manifest itself. Patients with this disease have little clinical implication. Few cases are admitted with hemolytic crisis although fava meal is one of traditional food recipes. G6PD deficient patients have also higher rate of neonatal jaundice. The molecular studies on G6PD deficient patient showed that 95% of patients had G6PD Mediterranean variant (nt 563 C T; 188 Ser Phe) 20,21. CONCLUSION This study shows that SCD incidence is less than 1% among the study group compared with previous studies in Bahrain. REFERENCES 1. Hereditary anaemias: genetic basis, clinical features, diagnosis, and treatment. WHO working group. Bull World Health Organ. 1982; 60:643-60. 2. Community control of hereditary anaemias: memorandum from a WHO meeting. Bull World Health Organ. 1983; 61:63-80. 3. Angastiniotis M, Kyriakidou S, Hadjiminas M. The Cyprus Thalassemia Control Program. Birth Defects: Original Articles Series 1988; 23:417-32. 4. Pembrey ME, Perrine RP, Wood WG, et al. Sickle thalassemia in Eastern Saudi Arabia. AM.J Hum Genet 1980; 32:26. 5. Gelpi AP. Sickle cell disease in Saudi Arabs. Acta Haematol. 1970; 43:89-99. 6. Bahrain Health Statistic Reports, 1985-2005 http://www.moh.gov.bh/pdf/leaflets/abstract/leaflet%202005.pdf 7. Nadkarni KV, Al-Arrayed SS, Bapat JP. Incidence of Genetic disorders of haemoglobin in the hospital population of Bahrain. Bahrain Medical Bulletin 1991; 131:19-24. 8. Mohammed A, Al-Hilli F, Nadkarni K, et al. Hemoglobinopathies and Glucose-6- Phosphate Dehydrogenase Deficiency in Hospital Birth in Bahrain. Annals of Saudi Medicine 1992; 12:536-9. 9. Al Arrayed SS. Premarital counseling. Eastern Mediterranean Health Journal 1997; 3:415-9. 10. Al-Arrayed SS, Hafadh N. Amin S, et al. Student screening for inherited blood disorders in Bahrain. East Mediterr Health J 2003; 9:344-51. 11. Al-Arrayed SS. The frequency of consanguineous marriages in the State of Bahrain. Bahrain Med Bull 1995; 17:63-6. 12. Bahrain National family Health Survey, BFHS 95, 1995 Bahrain. 13. Al-Arrayed SS, Neva H. Features of sickle-cell disease in Bahrain. East Mediterranean health journal 1995; 1:112-9. 14. Al-Arrayed S. The Nature of sickle-cell disease in Bahrain. Journal of the Bahrain Medical Society 1994; 6:125-30. 15. Al Arrayed S, Hamza A. A survey of Patients with sickle cell presentation to accident and emergency department of SMC Bahrain. Journal of Bahrain Medical Society 1995; 7:105-12. 16. Al-Arrayed S. Hematological characteristics in Bahraini sickle-cell disease patients. Journal of the Bahrain Medical Society 1991; 2:32-5. 18. Perrine RP, Pembrey ME, John P, et al. Natural history of sickle cell anemia in Saudi Arabs; a study of 270 subjects. Ann Intern Med 1978; 8:1-16.

19. El-Hazmi MAF. Hemoglobin disorders. A pattern thalassaemia and haemoglobinopathies in Arabia. Acta Haemat 1982; 68:43-51. 20. Luzzatto L, Nwachuku-Jarrett ES, et al. Increased sickling of parasitized erythrocytes is mechanism of resistance against malaria in sickle cell trait. Lancet 1970; 1:319-21. 21. Al-Momen NJ, Al-Arrayed SS, Al-Alawi AA. Molecular Homogeneity of G6PD Deficiency. Bahrain Med Bull 2004; 26:139-42.